content-documents/house-oversight-nov/13/HOUSE_OVERSIGHT_024634.md

---
title: "House Oversight: Estate Documents (Nov 12) (HOUSE_OVERSIGHT_024634)"
source: "House Oversight: Estate Documents (Nov 12)"
sourceUrl: "https://www.justice.gov/epstein"
date: "2026-01-01"
category: "House Oversight"
eftaNumber: "HOUSE_OVERSIGHT_024634"
ocrPages: 1
ocrChars: 1207
ocrElapsed: 0.0
parseTier: "external-legacy"
engine: "engine undisclosed (ep-nov-12.greg.technology mirror)"
externalSource: "greg-ep-nov-12"
externalLicense: "not granted"
externalCredit: "ep-nov-12.greg.technology"
externalUrl: "https://ep-nov-12.greg.technology"
---

$140,000
$120,000
$100,000
$80,000
$60,000
$40,000
U.S. Legalized Cannabis Market
Path to Federal Legalization
FDA Approves Cannabis-Derived Pharmaceuticals
More States Adopt Medical Cannabis Laws
More States Adopt Recreational Laws
FDA Routinely Approves CBD Drugs
FDA Routinely Approves THC Drugs
Federal Government Legalizes Cannabis
$20.000
So sore 3017
2018
- 70 M
60 M
- 50 M
- 40 M
- 30 M
- 20 M
- 10 M
2019
2020
2021
2022
2023
2024
2025
2026 2027
2028
2029
2030
0 M
Legalized Cannabis Market Size
Consumers
Source: Ackrell Capital. Assumes cannabis will be legalized federally by 2027. Cannabis may never be legalized federally in the United States.
Number of Consumers
Cannabis Industry Segments
Cultivation
Dispensaries
Production
Production
Equipment and
Supplies
Distribution
E-Commerce
Production and
Testing Services
Business Solutions
Business
Software
Flower
Distribution
Services
Consumer Products
Infused Products
Concentrates
Involves "touching the plant"
Business
Services
Digital Media
Online Content
and Networking
Online
Directories
Vaporizers and
Accessories
Pharmaceuticals
Does not involve "touching the plant"
© 2017 Ackrell Capital, LLC
| Member FINRA/SIPC
HOUSE_OVERSIGHT_024634